Condensed Consolidated Statements of Operations and Comprehensive Earnings (Loss) (Unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 31, 2018	Mar. 31, 2017	Mar. 31, 2018	Mar. 31, 2017
Income Statement [Abstract]
Operating revenues (net of contractual allowances)	$ 13,550	$ 13,883	$ 41,021	$ 41,321
Less provision for bad debts of Healthcare Facilities segment	133	184	363	321
Net revenues	13,417	13,699	40,658	41,000
Costs and Expenses
Cost of goods sold	5,073	5,523	14,623	15,592
Salaries, wages and benefits	6,045	5,872	17,697	17,476
Provision for bad debts of Pharmacy segment	237	126	445	342
Supplies	448	455	1,361	1,373
Purchased services	672	692	2,021	2,113
Other operating expenses	1,052	1,194	3,639	4,015
Rent and lease expense	157	142	471	409
EHR incentive payments	0	0	(21)	0
Depreciation and amortization	464	466	1,332	1,376
Operating Loss	(731)	(771)	(910)	(1,696)
Other Income (Expense):
Gain on sale of assets	183	2	181	3,019
Gain on economic damages claim, net	0	0	944	0
Loss on extinguishment of debt	0	0	(238)	(243)
Interest expense, net	(56)	(129)	(302)	(507)
Earnings (Loss) from Continuing Operations before income taxes	(604)	(898)	(325)	573
Income Tax Benefit	0	(8)	(296)	(236)
Earnings (Loss) from Continuing Operations	(604)	(890)	(29)	809
Earnings (Loss) from Discontinued Operations, net of tax	16	(135)	(110)	4,287
Net Earnings (Loss)	(588)	(1,025)	(139)	5,096
Other comprehensive income	0	0	0	0
Comprehensive Earnings (Loss)	$ (588)	$ (1,025)	$ (139)	$ 5,096
Continuing Operations:
Basic	$ (0.08)	$ (0.10)	$ 0.00	$ 0.09
Diluted	(0.08)	(0.10)	0.00	0.09
Discontinued Operations:
Basic	0.00	(0.01)	(0.01)	0.46
Diluted	0.00	(0.01)	(0.01)	0.45
Net Earnings (Loss):
Basic	(0.08)	(0.11)	(0.02)	0.54
Diluted	$ (0.08)	$ (0.11)	$ (0.02)	$ 0.54
Weighted-Average Common Shares Outstanding:
Basic	7,417	9,334	8,564	9,408
Diluted	7,417	9,334	8,564	9,429